This is a previous iteration Mercedes-Benz G 500 (G 550) with only a few miles under its belt that boasts some incredible ...

MIT researchers discovered that the genome’s 3D structure doesn’t vanish during cell division as previously thought. Instead, ...

Today, the Chan Zuckerberg Initiative (CZI) and NVIDIA announced an expanded collaboration to accelerate life science research by driving development and adoption of virtual cell models through tools, ...

Scientists are exploring leading-edge technologies that could transform how cancer is studied, detected and treated by catching it earlier, when it's more treatable and survival rates are highest.

This study presents valuable findings on the role of KLF6 in in vitro endothelial cells exposed to altered (high or low) shear stress with a customized microfluidic device to investigate mechanisms of ...

Opinion articles provide independent perspectives on key community issues, separate from our newsroom reporting. In 2023, Republican state lawmakers slipped a provision into the state budget ...

Novo Nordisk is ending all work in cell therapy, including a Type 1 diabetes program, amid CEO Maziar Mike Doustdar's reorganization. As part of the move, the company is laying off nearly all of the ...

Graham Kates is an investigative reporter covering criminal justice, privacy issues and information security for CBS News Digital. Contact Graham at [email protected] or [email protected] ...

OpenAI unveiled new API updates at its Dev Day on Monday, introducing GPT-5 Pro, its latest language model, its new video generation model Sora 2, and a smaller, cheaper voice model. The addition of ...

Oct 10 (Reuters) - Novo Nordisk (NOVOb.CO), opens new tab has decided to discontinue its cell therapy research and development efforts, a spokesperson for the Danish drugmaker told Reuters on Friday.